BIOSPAIN 2026

BIOSPAIN 2026

The leading biotechnology event in Southern Europe BIOSPAIN 2026 will be celebrated annually as of this year. This edition will be held in the Bilbao Exhibtion Centre from 29th September to 1st October 2026.

The event gathers companies, investors, institutions and professionals from across the global biotech ecosystem

The official BIOSPAIN 2026 website is now live, and delegate registration is open, along with the sale of exhibition spaces. Companies interested in showcasing their capabilities, strengthening their visibility and connecting with key stakeholders can now secure their booth and register attendees at the discounted early bird rates.

Last year’s edition confirmed the scale and impact of BIOSPAIN, with 2,400 registered attendees from 34 countries , +1,000 organisations, 140 investors from 76 diferent investmet firms, and 4,500 one-to-one meetings through the partnering platform.

BIOSPAIN 2026 will once again combine:

  • An international partnering platform with 30 minute on-site meetings.
  • A high-level conference agenda covering science, investment and innovation.
  • Multiple visibility and sponsorship opportunities, tailored to different strategic objectives.
  • Talent Day, a dedicated space connecting companies with biotech professionals and future talent.
  • Networking events where we combine fun with business.

Please, stay tuned for more information on the programme, speakers and activities which will be released in the coming months.

Register early and secure your place at BIOSPAIN 2026!

See you in Bilbao!


BioRN members receive a 10 % discount on ticket prices.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

Universität Heidelberg Successful with Application for Collaborative Research Centre

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp